In 2025, medical device manufacturers are grappling with heightened regulatory uncertainty, leading to slower reviews and communication difficulties with the FDA. This situation drives them to reassess operations for compliance and risk management, with a strong emphasis on maintaining product quality, which is vital for patient safety.
Why it Pays to Prioritize Quality Amid Regulatory Uncertainty
Related Posts
America Makes Announces Winners of $5.75M in AM
The National Center for Defense Manufacturing and Machining (NCDMM) and America Makes, the National Additive Manufacturing Innovation Institute,…
A 6-Step Guide to Web Application Testing
More and more web applications are being developed these days. And with each line of code being written,…
US Cutting Tool Orders Totaled $214.7 Million in April 2024, Raising Year-to-Date Total Nearly 5% Over 2023
Shipments of cutting tools, measured by the Cutting Tool Market Report compiled in a collaboration between AMT –…